CBD

Canadian cannabis company adds Polish hemp grower to European portfolio

A Canadian cannabis company has bought a Polish hemp firm to expand CBD production in Europe. ICC International Cannabis Corp. announced Tuesday that it has acquired Polannabis Holdings, which includes a company that grows 850 acres of hemp and has licenses to extract CBD. ICC is paying 2.5 million Canadian dollars ($1.9 million) and 26.5 […]

Read More

RI allows medical marijuana to treat autism – after trying FDA-approved CBD

A Rhode Island decision to expand medical marijuana access has a worrying caveat for many in the CBD industry: Patients must first try an FDA-approved version of the drug. That classification by the Food and Drug Administration is currently limited to Epidiolex, an epilepsy treatment made by United Kingdom-based pharmaceutical manufacturer GW Pharmaceuticals. Rhode Island’s health department […]

Read More

Chart: Opportunity in CBD-only stores limited, but strong growth expected for other channels

As state laws around cannabidiol continue to change, stand-alone CBD stores may become a relic. According to estimates from Hemp Industry Daily in the 2018 Hemp & CBD Industry Factbook, CBD sales in the U.S. are expected to exceed $1 billion by 2020. More than half (55%) of retail respondents to a survey for the Factbook described their stores are […]

Read More

Canadian cannabis company starts US hemp firm, citing looser regulations

Noting hemp’s relaxed oversight compared to marijuana, a Canadian cannabis company has launched a new hemp company and signed a $500,000 CBD deal with a Kentucky hemp producer. Ascent Industries announced the creation of Thirty Eight Hemp Co. to produce CBD products for sale in the United States. Vancouver, British Columbia-based Ascent also inked a […]

Read More

Walmart Canada ‘fact-finding’ on potential for CBD product sales

The world’s largest retailer, Walmart, is considering selling CBD products in Canada, a development that comes just days before recreational marijuana markets open in the country. But Walmart says it isn’t ready to start selling cannabidiol just yet. “As we would for any new industry, Walmart Canada has done some preliminary fact-finding on this issue,” […]

Read More

CBD manufacturer Mile High Labs closes $35 million Series A funding round

Loveland, Colorado-based Mile High Labs – a manufacturer of CBD crude oil, distillate and isolate – closed a $35 million Series A funding round as it works to expand its operations. The raise was led by institutional investors from the United States and Europe, as well as family offices and a venture capital fund. The company […]

Read More

Ottawa hemp company to buy natural-products manufacturer for CA$20M to boost product research

A Canadian hemp company is buying a natural-products manufacturer for $20 million Canadian dollars ($15.4 million) in a bid to accelerate development of CBD consumer goods. Ottawa-based LiveWell Canada agreed to acquire Acenzia, which manufactures neutraceuticals, including powders and sports drinks, in a 36,000-square-foot facility in Tecumseh, Ontario. The acquisition gives LiveWell (TSXV: LVWL) a place […]

Read More

GW Pharmaceuticals poised to raise $300 million in stock offering

Cannabis biopharmaceutical company  GW Pharmaceuticals is setting out to sell $300 million worth of U.S. depository shares. The London-based company’s announcement comes on the heels of the U.S. Drug Enforcement Administration’s move to take some cannabidiol products off the most restrictive class of controlled substances. That change will allow Epidiolex – a CBD drug manufactured by GW Pharmaceuticals […]

Read More

FDA: CBD shouldn’t be a controlled substance, but treaties require it

The U.S. Food and Drug Administration noted that cannabidiol shouldn’t be a controlled substance, but international treaties require the United States to treat it as one. That revelation from the federal agency appeared in a 27-page memo written after it approved the first drug made with CBD earlier this year. “CBD has negligible potential for abuse,” wrote Dr. Brett […]

Read More